Skip to main content
Premium Trial:

Request an Annual Quote

Nanogen Appoints Gerald Wills as CFO

NEW YORK, April 30 - Nanogen has appointed Gerald Wills, formerly the chief
financial officer of Trega Biosciences, as its vice president and chief financial officer, the San Diego-based company said Monday.

Wills, 48, will replace the current CFO Kieran Gallahue, who will now work solely as president of Nanogen.

Wills served in his position at Trega from 1999 until it was acquired by Lion Biosciences in March. Previously, Wills was chief financial officer of cardiac testing biotech company Molecular Biosystems.

Additionally, Nanogen reported that Randy White, the executive vice president of technical operations and R&D at American Medical Laboratories, has joined the company's board of directors.

Recently, White facilitated a collaboration between Nanogen and AML. Nanogen hopes the deal will lead to the development of molecular diagnostic assays for its NanoChip molecular biology workstation.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.